Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2018

Open Access 01-12-2018 | Research article

Predictors of vascular complications among type 2 diabetes mellitus patients at University of Gondar Referral Hospital: a retrospective follow-up study

Authors: Haileab Fekadu Wolde, Asrat Atsedeweyen, Addisu Jember, Tadesse Awoke, Malede Mequanent, Adino Tesfahun Tsegaye, Shitaye Alemu

Published in: BMC Endocrine Disorders | Issue 1/2018

Login to get access

Abstract

Background

Type 2 Diabetes Mellitus is a serious metabolic disease that is often associated with vascular complications. There are 1.9 million people living with Diabetes in Ethiopia; diabetes mellitus is found to be the ninth leading cause of death related to its complications. Although the rate of vascular complications continues to rise, there is limited information about the problem. This study aimed to estimate the incidence and predictors of vascular complications among type 2 diabetes mellitus patients at University of Gondar Referral Hospital.

Methods

Institution based retrospective follow-up study was conducted at University of Gondar Referral Hospital with 341 newly diagnosed type 2 DM patients from September 2005 to March 2017 and the data were collected by reviewing their records. Schoenfeld residuals test and interaction of each covariate with time were used to check proportional hazard assumption. The best model was selected by using Akaike Information Criteria (AIC). Hazards ratio (HR) with its respective 95% confidence interval were reported to show strength of association.

Result

The selected patients were followed retrospectively for a median follow up time of 81.50 months (Inter quartile range (IQR) = 67.2–103.3). The mean age (± Standard deviation (SD)) of patients at baseline was 51.7(SD: ±11.5 years) and 57.48% were females. The incidence rate of vascular complications was 40.6 cases/ 1000 person years of observation. The significant predictors for vascular complications where found to be male sex (Adjusted hazard ratio (AHR) = 0.50, 95% CI: 0.27, 0.94), having hypertension at baseline(AHR = 3.99, 95% CI: 1.87, 8.56), positive protein urea at base line (AHR = 1.69, 95% CI: 1.03, 2.78), high density lipoprotein cholesterol(HDL-C) level ≥ 40 mg per deciliter (mg/dl) (AHR = 0.43, 95% CI: 0.24, 0.77), low density lipoprotein cholesterol(LDL-C) level > 100 mg/dl (AHR = 3.05, 95% CI: 1.47, 6.35) and triglyceride > 150 mg/dl (AHR = 2.74, 95% CI: 1.28, 5.84).

Conclusion

The incidence of vascular complications among type 2 diabetes patients remains a significant public health problem. Hypertension at baseline, LDL-C > 100 mg/dl, triglyceride > 150 mg/dl, HDL-C ≥ 40 mg/dl and male sex were significant predictors of vascular complication. In the light of these findings targeted interventions should be given to diabetes patients with hypertension comorbidity and dyslipidemia at follow up clinics.
Literature
1.
go back to reference WHO, Definition, diagnosis and classification of diabetes mellitus and its complications. 1999. WHO, Definition, diagnosis and classification of diabetes mellitus and its complications. 1999.
2.
3.
go back to reference IDF, International diabeties federation. Diabetes Atlas 7th edition. Brusseles; 2015. IDF, International diabeties federation. Diabetes Atlas 7th edition. Brusseles; 2015.
4.
go back to reference IDF, report of non-commncaiable disease. 2015. IDF, report of non-commncaiable disease. 2015.
5.
go back to reference Ahmed KA, Muni S, Ismail IS. Type 2 diabetes and vascular complications: a pathophysiologic view. Biomed Res. 2010;21(2):147–55. Ahmed KA, Muni S, Ismail IS. Type 2 diabetes and vascular complications: a pathophysiologic view. Biomed Res. 2010;21(2):147–55.
6.
go back to reference Naicker S. Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol. 2010;74:S13–6.PubMed Naicker S. Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol. 2010;74:S13–6.PubMed
7.
go back to reference Yirsaw B. Chronic kidney disease in sub-Saharan Africa: hypothesis for research demand. Ann Afr Med. 2012;11(2):119.CrossRefPubMed Yirsaw B. Chronic kidney disease in sub-Saharan Africa: hypothesis for research demand. Ann Afr Med. 2012;11(2):119.CrossRefPubMed
8.
go back to reference Ejigu A. Brief communication: patterns of chronic complications of diabetic patients in Menelik II hospital, Ethiopia. Ethiop J Health Dev. 2000;14(1):113–6.CrossRef Ejigu A. Brief communication: patterns of chronic complications of diabetic patients in Menelik II hospital, Ethiopia. Ethiop J Health Dev. 2000;14(1):113–6.CrossRef
9.
go back to reference Abebe SM, et al. Increasing trends of diabetes mellitus and body weight: a ten year observation at Gondar university teaching referral hospital, Northwest Ethiopia. PLoS One. 2013;8(3):e60081.CrossRefPubMedPubMedCentral Abebe SM, et al. Increasing trends of diabetes mellitus and body weight: a ten year observation at Gondar university teaching referral hospital, Northwest Ethiopia. PLoS One. 2013;8(3):e60081.CrossRefPubMedPubMedCentral
10.
go back to reference Berry J, Keebler ME, McGuire DK. Diabetes mellitus and cardiovascular disease. Herz. 2004;29(5):456–62.CrossRefPubMed Berry J, Keebler ME, McGuire DK. Diabetes mellitus and cardiovascular disease. Herz. 2004;29(5):456–62.CrossRefPubMed
11.
12.
go back to reference IDF, DF report of non-commncaiable disease. 5th edition 2012;Atlas, Brussels: IDF. IDF, DF report of non-commncaiable disease. 5th edition 2012;Atlas, Brussels: IDF.
13.
go back to reference Raman R, et al. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type 2 diabetes mellitus. Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS, report 27). J Diabetes Complicat. 2012;26(2):123–8.CrossRefPubMed Raman R, et al. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type 2 diabetes mellitus. Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS, report 27). J Diabetes Complicat. 2012;26(2):123–8.CrossRefPubMed
14.
go back to reference Muluneh LBaEK. Correlates of time to microvascular complications among diabetes mellitus patients usingparametric and non-parametric approaches: a case study of Ayder referral hospital, Ethiopia. Ethiop J Sci Technol. 2017;10(1):65–80.CrossRef Muluneh LBaEK. Correlates of time to microvascular complications among diabetes mellitus patients usingparametric and non-parametric approaches: a case study of Ayder referral hospital, Ethiopia. Ethiop J Sci Technol. 2017;10(1):65–80.CrossRef
15.
go back to reference Sadeghpour S, et al. Predictors of all-cause and cardiovascular-specific mortality in type 2 diabetes: a competing risk modeling of an Iranian population. Adv Biomed Res. 2016;5(1):82.CrossRefPubMedPubMedCentral Sadeghpour S, et al. Predictors of all-cause and cardiovascular-specific mortality in type 2 diabetes: a competing risk modeling of an Iranian population. Adv Biomed Res. 2016;5(1):82.CrossRefPubMedPubMedCentral
17.
go back to reference Agrawal R, et al. Prevalence of micro and macrovascular complications and their risk factors in type-2 diabetes mellitus. JAPI. 2014;62:505. Agrawal R, et al. Prevalence of micro and macrovascular complications and their risk factors in type-2 diabetes mellitus. JAPI. 2014;62:505.
18.
go back to reference Bentata Y, et al. Diabetic kidney disease and vascular comorbidities in patients with type 2 diabetes mellitus in a developing country. Saudi J Kidney Dis Transpl. 2015;26(5):1035–43.CrossRefPubMed Bentata Y, et al. Diabetic kidney disease and vascular comorbidities in patients with type 2 diabetes mellitus in a developing country. Saudi J Kidney Dis Transpl. 2015;26(5):1035–43.CrossRefPubMed
19.
go back to reference Choukem SP, et al. Comparison of different blood pressure indices for the prediction of prevalent diabetic nephropathy in a sub-Saharan African population with type 2 diabetes. Pan Afr Med J. 2012;11:67.PubMedPubMedCentral Choukem SP, et al. Comparison of different blood pressure indices for the prediction of prevalent diabetic nephropathy in a sub-Saharan African population with type 2 diabetes. Pan Afr Med J. 2012;11:67.PubMedPubMedCentral
20.
go back to reference Agrawal RP, et al. Prevalence of micro and macrovascular complications and their risk factors in type-2 diabetes mellitus. J Assoc Physicians India. 2014;62(6):504–8.PubMed Agrawal RP, et al. Prevalence of micro and macrovascular complications and their risk factors in type-2 diabetes mellitus. J Assoc Physicians India. 2014;62(6):504–8.PubMed
21.
go back to reference Litwak L, et al. Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational a 1 chieve study. Diabetol Metab Syndr. 2013;5(1):57.CrossRefPubMedPubMedCentral Litwak L, et al. Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational a 1 chieve study. Diabetol Metab Syndr. 2013;5(1):57.CrossRefPubMedPubMedCentral
22.
go back to reference Lekshmi Narayanan RM, et al. Peripheral arterial disease in community-based patients with diabetes in Singapore: results from a primary healthcare study. Ann Acad Med Singap. 2010;39(7):525–7.PubMed Lekshmi Narayanan RM, et al. Peripheral arterial disease in community-based patients with diabetes in Singapore: results from a primary healthcare study. Ann Acad Med Singap. 2010;39(7):525–7.PubMed
23.
go back to reference Marathe PH, Gao HX, Close KL. American Diabetes Association standards of medical care in diabetes 2017. J Diabetes. 2017;9(4):320–4.CrossRefPubMed Marathe PH, Gao HX, Close KL. American Diabetes Association standards of medical care in diabetes 2017. J Diabetes. 2017;9(4):320–4.CrossRefPubMed
24.
go back to reference Longo D, et al. Harrison’s principles of internal medicine: volumes 1 and 2. New York: McGraw-Hill; 2012. Longo D, et al. Harrison’s principles of internal medicine: volumes 1 and 2. New York: McGraw-Hill; 2012.
25.
go back to reference Parati G, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32(7):1359–66.CrossRefPubMed Parati G, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32(7):1359–66.CrossRefPubMed
26.
go back to reference Marchesini G, et al. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with type 2 diabetes. Diabet Med. 2004;21(4):383.CrossRefPubMed Marchesini G, et al. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with type 2 diabetes. Diabet Med. 2004;21(4):383.CrossRefPubMed
27.
go back to reference Expert Panel on Detection, E. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486.CrossRef Expert Panel on Detection, E. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486.CrossRef
28.
29.
go back to reference Abu-lebdeh HS, Nguyen TT. Predictors of Macrovascular Disease in Patients WithType 2 Diabetes Mellitus. Mayo Foundation for Medical Education and Research. 2001;76:707–12. Abu-lebdeh HS, Nguyen TT. Predictors of Macrovascular Disease in Patients WithType 2 Diabetes Mellitus. Mayo Foundation for Medical Education and Research. 2001;76:707–12.
30.
go back to reference Bastawrous A, et al. The incidence of diabetes mellitus and diabetic retinopathy in a population-based cohort study of people age 50 years and over in Nakuru, Kenya. BMC Endocr Disord. 2017;17(1):19.CrossRefPubMedPubMedCentral Bastawrous A, et al. The incidence of diabetes mellitus and diabetic retinopathy in a population-based cohort study of people age 50 years and over in Nakuru, Kenya. BMC Endocr Disord. 2017;17(1):19.CrossRefPubMedPubMedCentral
31.
go back to reference Amutha A, et al. Incidence of complications in young-onset diabetes: comparing type 2 with type 1 (the young diab study). Diabetes Res Clin Pract. 2017;123:1–8.CrossRefPubMed Amutha A, et al. Incidence of complications in young-onset diabetes: comparing type 2 with type 1 (the young diab study). Diabetes Res Clin Pract. 2017;123:1–8.CrossRefPubMed
32.
go back to reference Collaboration, E.R.F. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.CrossRef Collaboration, E.R.F. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.CrossRef
33.
go back to reference Maric-Bilkan C. Sex differences in micro-and macro-vascular complications of diabetes mellitus. Clin Sci. 2017;131(9):833–46.CrossRefPubMed Maric-Bilkan C. Sex differences in micro-and macro-vascular complications of diabetes mellitus. Clin Sci. 2017;131(9):833–46.CrossRefPubMed
34.
go back to reference Carpenter MW. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care. 2007;30(Supplement 2):S246–50.CrossRefPubMed Carpenter MW. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care. 2007;30(Supplement 2):S246–50.CrossRefPubMed
35.
go back to reference ADA. Standards of medical care in diabetes. Diabetes Care. 2008;31:S12–54.CrossRef ADA. Standards of medical care in diabetes. Diabetes Care. 2008;31:S12–54.CrossRef
36.
go back to reference Tracey ML, et al. Risk factors for macro-and microvascular complications among older adults with diagnosed type 2 diabetes: findings from the Irish longitudinal study on ageing. J Diabetes Res. 2016;2016:5975903.CrossRefPubMedPubMedCentral Tracey ML, et al. Risk factors for macro-and microvascular complications among older adults with diagnosed type 2 diabetes: findings from the Irish longitudinal study on ageing. J Diabetes Res. 2016;2016:5975903.CrossRefPubMedPubMedCentral
37.
go back to reference Hsueh WA, Anderson PW. Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension. 1992;20(2):253–63.CrossRefPubMed Hsueh WA, Anderson PW. Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension. 1992;20(2):253–63.CrossRefPubMed
38.
go back to reference Tapera, S., Prevalence and Risk Factors for Diabetes Chronic Complications in Harare, Zimbabwe, 2014. 2014, University of Zimbabwe. Tapera, S., Prevalence and Risk Factors for Diabetes Chronic Complications in Harare, Zimbabwe, 2014. 2014, University of Zimbabwe.
39.
go back to reference Link JJ, Rohatgi A, de Lemos JA. HDL cholesterol: physiology, pathophysiology, and management. Curr Probl Cardiol. 2007;32(5):268–314.CrossRefPubMed Link JJ, Rohatgi A, de Lemos JA. HDL cholesterol: physiology, pathophysiology, and management. Curr Probl Cardiol. 2007;32(5):268–314.CrossRefPubMed
40.
go back to reference Trialists CT. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581–90.CrossRef Trialists CT. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581–90.CrossRef
41.
go back to reference Carroll MF. Proteinuria in Adults: A Diagnositc Approach. Am Fam Physician. 2000;62(6):1333–40.PubMed Carroll MF. Proteinuria in Adults: A Diagnositc Approach. Am Fam Physician. 2000;62(6):1333–40.PubMed
Metadata
Title
Predictors of vascular complications among type 2 diabetes mellitus patients at University of Gondar Referral Hospital: a retrospective follow-up study
Authors
Haileab Fekadu Wolde
Asrat Atsedeweyen
Addisu Jember
Tadesse Awoke
Malede Mequanent
Adino Tesfahun Tsegaye
Shitaye Alemu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2018
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-018-0280-0

Other articles of this Issue 1/2018

BMC Endocrine Disorders 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.